Amylyx Pharmaceuticals (AMLX) Net debt US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
Net debt, bln rub -96.1 -340.7 -367.1 -174.5 -311.0   -274.1  
Changes by years, y/y, % +739% +254% +8% -52% +78%     +93.5%

Amylyx Pharmaceuticals. Net debt, bln rub

Amylyx Pharmaceuticals. Net debt, changes, %

Amylyx Pharmaceuticals (AMLX) Net debt US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
Net debt, bln rub -202.7 -174.9 -338.1 -311.0 -274.1   -274.1
Changes by years, y/y, % -45% -43% +46% +78% +35%    
Changes by quarters, q/q, % +16% -14% +93% -8% -12%    

Amylyx Pharmaceuticals. Net debt, bln rub

Amylyx Pharmaceuticals. Net debt, changes, y/y, %

Amylyx Pharmaceuticals. Net debt, changes, q/q, %